Bronchitis? ENTB Can Help With That 
The great thing about this company-outside of the stock performance (and it's been exceptional today, generally speaking) itself-is that the work it's doing may eventually lead to therapies that could address issues like bronchial inflammation and similar illnesses.
I suspect that much, if not all, of the conditions that afflict us have at their base a genetic component, either wholly or in part. If you can unlock that key and make use of certain stem cell modalities to treat them, then the sky's literally the limit!
The price fell back just a smidgen on sell-offs and profit taking. I'd watch the next few hours to see if pressure builds up again before a final PM sell-off and profit taking occurs.
The great thing about this company-outside of the stock performance (and it's been exceptional today, generally speaking) itself-is that the work it's doing may eventually lead to therapies that could address issues like bronchial inflammation and similar illnesses.
I suspect that much, if not all, of the conditions that afflict us have at their base a genetic component, either wholly or in part. If you can unlock that key and make use of certain stem cell modalities to treat them, then the sky's literally the limit!
The price fell back just a smidgen on sell-offs and profit taking. I'd watch the next few hours to see if pressure builds up again before a final PM sell-off and profit taking occurs.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
